Gadopiclenol Patent Expiration

Gadopiclenol was first introduced by Guerbet in its drug Elucirem on Sep 21, 2022.

Gadopiclenol Patents

Given below is the list of patents protecting Gadopiclenol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Elucirem	US11590246	Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process	Jan 17, 2040	Guerbet
Elucirem	US10973934	Gadolinium bearing PCTA-based contrast agents	Aug 06, 2039	Guerbet
Elucirem	US8114863	Compounds comprising short aminoalcohol chains and metal complexes for medical imaging	Sep 19, 2028	Guerbet

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List